lymphoma+case+study
Post on 04-Jun-2018
216 Views
Preview:
TRANSCRIPT
-
8/13/2019 Lymphoma+Case+Study
1/12
"
#$%& '(") *+,-./,$ 01&$2&3 452. #.&,/2.&1$-+
67 893&1%2$9359: 2.& ;5%&$%& $93 2(3)$+3%" #$%&7+*1 =&%;* >> 3*%.? %.7 $+: 7+*1 $*/ )$(10-%2 *@%30.%&0+. 16))+/&&$014
@2$:& 66 =+,-./,$ ,&$9% 2.$2 2.& >$9>&1 5% ?/B93 59 24/ /1 ,/1& =+,-.
9/3& :1/B-% 2.$2 5% $F/C& /1 F&=/4 2.& 35$-.1$:,7 0.5% $1&$ 5% 2.& 2.59
,B%>=& F&=/4 2.& =B9:% 2.$2 .&=-% F1&$2.59: $93 %&-$1$2&% 2.& >.&%2 ?1/,
2.& $F3/,&97 M&1 -.+%5>$= &A$,59$25/9 %B--/12% 2.5% ?1/, 2.& $F9/1,$==+,-. 9/3&%7
A" B*.*/%22(? )%&0*.&1 :0&$ -%.-*/ %/* &/*%&*7 :0&$ 16/;*/(? /%70%&0+.&$*/%)(? -$*3+&$*/%)(? C0+2+;0-%2 &$*/%)(? C+.* 3%//+: &/%.1)2%.&?
+/ % -+3C0.%&0+. +, &$*/%)0*1" 81" 80&-$*2291 3*70-%2 )2%. 0.70-%&*1&$%& 1$* :022 $%D* C+&$ -$*3+&$*/%)( %.7 /%70%&0+. &$*/%)("
E*1-/0C* $+: *%-$ +, &$*1* &$*/%)( 3+7%20&0*1 :+/F1 &+ &/*%&
3%20;.%.& -*221"
@B1:&1+)@B1:&1+ 5% B%&3 ,/1& /?2&9 2/ 35$:9/%& N/9OM/3:E59P% *+,-./,$
2.$9 ?/1 21&$2,&927 @B1:&1+ 5% ,/%2 >/,,/9=+ B%&3 2/ /F2$59 $
F5/-%+ %$,-=& $93 ?/1 21&$2,&927
Q$35$25/9 2.&1$-+)01&$2,&92 2.$2 59>=B3&% 1$35$25/9 $93 .5:.O&9&1:+ AO1$+% 2/ E5==
>$9>&1 >&==% $93 -1&C&92 2.&51 :1/42.7 0.& 24/ 2+-&% /? 1$35$25/9$1& &A2&19$=D B%59: $ ,$>.59& /B2%53& 2.& F/3+ 2/ %&93 1$35$25/9 2/
2.& >$9>&1 $93 592&19$=D 4.5>. B%&% $ 1$35/$>25C& %BF%2$9>& %&$=&359 9&&3=&% /1 >$2.&2&1% -=$>&3 592/ /1 9&$1 2.& >$9>&17
#.&,/2.&1$-+)01&$2,&92 59C/=C59: 31B:% 2.$2 %2/- 2.& :1/42. /? >$9>&1 >&==% F+
E5==59: 2.&, /1 %2/--59: 2.&, ?1/, 35C5359:7 Q&:5/9$=
>.&,/2.&1$-+ 5% /9& 2+-& 4.&1& 2.& >.&,/2.&1$-+ 5% -=$>&3 59
2.& %-59$= >/=B,9D $9 /1:$9D /1 F/3+ >$C52+ 2.$2 $??&>2% 2.& >$9>&1
59 $ %-&>5?5> $1&$7 0.& %&>/93 2+-& 5% >$==&3 %+%2&,5>
-
8/13/2019 Lymphoma+Case+Study
2/12
G
>.&,/2.&1$-+D 4.5>. 5% 2$E&9 F+ ,/B2. /1 59R&>2&3 592/ 2.&
,B%>=& /1 C&597 0.5% 2+-& /? >.&,/2.&1$-+ &92&1% 2.& F=//3%21&$,$93 1&$>.&% >$9>&1 >&==% 2.1/B:./B2 2.& F/3+7 0.& =$%2 5% B%&3 2/
21&$2 >&12$59 2+-&% /? =+,-./,$ 59 2.& F1$59 $93 5% >$==&3 #N@-1/-.+=$A5%7
H5/=/:5>$= 2.&1$-+)I 21&$2,&92 2.$2 ?5:.2% >$9>&1 B%59: 2.& -$25&92P% 5,,B9& %+%2&,70.& 21&$2,&92 1&%2/1&%D F//%2%D /1 351&>2% 2.& F/3+P% 9$2B1$=
3&?&9%&% $:$59%2 >$9>&1 F+ B%59: %BF%2$9>&% ,$3& F+ 2.& F/3+ /1
,$3& 59 $ =$F/1$2/1+7
H/9& ,$11/4 21$9%-=$92)H/9& ,$11/4 21$9%-=$92 5% $ ?/1, /? 21&$2,&92 B%&3 ?/1 -$25&92%
452. H >&== =+,-./,$7 0.& 21&$2,&92 B%&% ,/9/>=/9$= $925F/3+
Q52BA$9 2/ >=&$9 /B2 2.& >$9>&1 59 2.& F/9& ,$11/4 F&?/1& 2.&.$1C&%2 /? 2.& F=//3 %2&, >&==% 4.5>. .&=-% >=&$1 2.& F/3+P%
1&,$5959: =+,-./,$7
0.& #=&C&=$93 #=595>) ;5%&$%&% $93 #/93525/9%7
QB%. S&35>$= #&92&1) N/9OM/3:E59P% *+,-./,$OH/9& S$11/4
01$9%-=$92 #&92&17
G" H%70%&0+. %.7 -$*3+&$*/%)( 3%( %21+ %,,*-& $*%2&$( &0116*1"%" #$%& +&$*/ -*221 0. &$* C+7( 3%( C* %,,*-&*7 C( *0&$*/ +/ C+&$
+, &$*1* &/*%&3*.&14
#.&,/2.&1$-+ $93 1$35$25/9 $??&>2% >&==% 2.$2 $1& ?1&TB&92=+
35C5359:D %B>. $% F/9& ,$11/4 >&==% U1&3 F=//3 >&==%D 4.52& F=//3
>&==%D $93 -=$2&=&2%VD 2.& &-52.&=5$= =5959: /? 2.& :$%21/592&%259$=
21$>2D =+,-. 25%%B&D $93 2.& >&==% /? 2.& .$51 ?/==5>=&%7C" #$%& 1(3)&+31 3%( &$* )%&0*.& *@)*/0*.-* %1 % /*162& +, &$*7*1&/6-&0+. +, &$*1* -*2214@53& &??&>2% /? >.&,/2.&1$-+ $1& >$B%&3 F+ 2/A5>52+ 2/ 2.& >&==% $93
59>=B3& 9$B%&$ $93 C/,5259:D 2.1/,F/>+2/-&95$D $9&,5$D 35$11.&$D
,B>/%525%D $93 $=/-&>5$7 W??&>2% /? 1$35$25/9 59>=B3& 3&=$+&34/B93 .&$=59:D ?$25:B&D ,B>/%525%D 3+%:&B%5$D A&1/%2/,5$
%&>/93$1+ 2/ %$=5C$1+ :=$93 3&%21B>25/9D /3+9/-.$:5$D %&C&1&
&%/-.$:525%D >.1/95> ,$=$F%/1-25/9D $93 35$11.&$7
!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93&37 H&=,/92D #IJ
K$3%4/12. #&9:$:& *&$1959:J GL""7
667 893&1%2$9359: 2.& NB21525/9 0.&1$-+I" E*1-/0C* &$* 3%J+/ ,%-&+/1 &$%& 3%( 03)%-& &$* .6&/0&0+.%2 1&%&61 +,
&$* -%.-*/ )%&0*.&"
#$>.&A5$) 69>=B3&% 59C/=B92$1+ 4&5:.2 =/%%D 25%%B& 4$%259:D59$F5=52+ 2/ -&1?/1, 3$5=+ $>25C525&%D $93 ,&2$F/=5> $=2&1$25/9%7NB21525/9 $93 ,&35>$= %2$2B% >$9 F& 5,-$>2&3 F+ $=2&1$25/9% 59
:=B>/%&D $,59/ $>53 -1/2&59D $93 =5-53 ,&2$F/=5%,7
-
8/13/2019 Lymphoma+Case+Study
3/12
(
N$B%&$ $93 C/,5259:) #$B%&% 59>=B3& >.&,/2.&1$-+D 1$35$25/9D9$1>/25> $9$=:&%5>%D /3/1% $93 3&=$+&3 :$%215> &,-2+59:7
W$1=+ %$25&2+) X>>B1% 4.&9 -$25&92% >$99/2 &$2 C&1+ ,B>. F&>$B%&/? :&2259: ?B== TB5>E=+7 0.& -15,$1+ >$B%& /? &$1=+ %$25&2+ 5% 3&=$+&3
:$%215> &,-2+59:7
SB>/%525%) I=%/ E9/49 $% %2/,$2525%D 3&%>15F&3 F+ 51152$25/9% $9359?=$,,$25/9 /? 2.& &-52.&=5$= >&==% =5959: 2.& Y6 21$>27 #$B%&% /?,B>/%525% 59>=B3& C51$=D F$>2&15$=D $93 ?B9:$= 59?&>25/9%D 1$35$25/9D
%2&, >&== 21$9%-=$92 2.&1$-+D $93 :1$?2OC&1%B%O./%2 3&?&9%&7
;5$11.&$) I9259&/-=$%25> $:&92% 2$1:&2 >&==% 2.$2 .$C& 2.& .5:.&%21&-=5>$25/9 1$2& $93 2.&1&?/1& >$B%& 35$11.&$7
;+%:&B%5$) I=2&1$25/9% 59 2$%2& 2.$2 .$C& $ -1/?/B93 &??&>2 /9 $95935C53B$=P% $F5=52+ 2/ 59:&%2 $9 $3&TB$2& $,/B92 /? 9B21525/97
Z&1/%2/,5$) Q&3B>&3 %$=5C$ -1/3B>25/9 >$9 F& $ %53& &??&>2 /?1$35$25/9 $93 >.&,/2.&1$-+D 3&.+31$25/9D >.1/95> :1$?2OC&1%B%O
./%2 35%&$%& /? 2.& Y6 21$>2D ,&35>$25/9%D $93 $:59:7
I9/1&A5$) *$>E /? $--&252& $93 1&3B>&3 ?//3 592$E& ?1&TB&92=+/>>B1% 59 >$9>&1 -$25&92% F&>$B%& /? ./1,/9& >.$9:&%D 3&-1&%%5/9D
?$25:B&D $93 ,&35>59&7
!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93&37 H&=,/92D #IJ
K$3%4/12. #&9:$:& *&$1959:J GL""7
K" L+6 $%D* /*%7 &$%& 3+1& -%.-*/ )%&0*.&1 /*M60/* %770&0+.%2 *.*/;(%.7 )/+&*0." N@)2%0. &$* /%&0+.%2* ,+/ &$01" >1 &$01 &/6* ,+/ *D*/(
-%.-*/ )%&0*.&4
#$9>&1 -$25&92% 1&TB51& $33525/9$= &9&1:+ F&>$B%& /? 2.& ,&2$F/=5>
$=2&1$25/9% 2.$2 =&$3 2/ 59>1&$%&3 &9&1:+ &A-&9352B1&7 0.&%& $=2&1$25/9%
$1& >$B%&3 F+ .5:.&1 =&C&=% /? #O1&$>25C& -1/2&59%D ?5F159/:&9D 4.52& F=//3>&==%D $93 -1/O59?=$,,$2/1+ >+2/E59&%7 H5/>.&,5>$= $F9/1,$=525&% />>B1F&>$B%& /? 59%B=59 1&%5%2$9>&D 59>1&$%&3 :=B>/%& %+92.&%5%D
:=B>/9&/:&9&%5%D 59>1&$%&3 #/15 >+>=& $>25C52+D $93 3&>1&$%&3 :=B>/%&
2/=&1$9>& $93 2B19/C&17 0.& >.$9:&% 59 >$1F/.+31$2& ,&2$F/=5%, >$B%&%
2.& ?B25=& >+>=& 2/ />>B1 $93 1&%B=2% 59 59>1&$%&3 &9&1:+ &A-&9352B1&7
I33525/9$==+D -1/2&59% 2B19/C&1 5% 59>1&$%&3 >$B%59: $9 59>1&$%&3 2B,/13&,$93 ?/1 $,59/ $>53% $93 59>1&$%&3 -1/2&59 =/%%&%7 SB%>=& 4$%259:
$=%/ />>B1% $% $ 1&%B=2 /? 59>1&$%&3 -1/2&59 >$2$F/=5%, /1 3&>1&$%&3
-1/2&59 %+92.&%5%7 0.5% 5% 9/2 21B& ?/1 &C&1+ -$25&92 $% 2.& 5935C53B$=D $93
2.& %2$:& $93 2+-& /? >$9>&1 59?=B&9>& &$>. >$%&7
!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93
&37 H&=,/92D #IJK$3%4/12. #&9:$:& *&$1959:J GL""7
>. M6*1&0+. G? (+6 201&*7 &$* 1)*-0,0- 1(3)&+31 &$%& % )%&0*.& 3%( *@)*/0*.-*,/+3 -$*3+&$*/%)( %.7 /%70%&0+. &$*/%)(" O+/ *%-$? 7*1-/0C* &$* .6&/0&0+.
&$*/%)( /*-+33*.7%&0+.1 &$%& :+627 C* %))/+)/0%&* &+ %1101& 0. &/*%&3*.& +,&$%& 1(3)&+3"
N$B%&$ $93 C/,5259:)o @,$==D =/4O?$2 ,&$=% 2.& ,/1959: /?
-
8/13/2019 Lymphoma+Case+Study
4/12
[
o IC/53 ?15&3 $93 :1&$%+ ?//3%o IC/53 ?$C/152& ?//3%o #=&$1 =5TB53 35&2D &=&>21/=+2&O?/125?5&3 F&C&1$:&%D 9/9O$>535>
?1B52 3159E%D $C/53 >1&$,+ 9B21525/9$= 3159E%
;5$11.&$o ;159E %,$== $,/B92% ?1&TB&92=+o IC/53 =$1:& $,/B92% /? ?1B52 RB5>&o NB21525/9$= F&C&1$:&o \//3% .5:. 59 %/=BF=& ?5F&1
SB>/%525%)o W$2 %/?2D 9/9O?5F1/B%D 9/9O$>535> ?//3%o IC/53 ./2 ?//3%o W9>/B1$:& =5TB53%D 9/9O$>535> RB5>&%D .5:. E5=/>$=/15&D .5:.
-1/2&59 %.$E&% $93 %B--=&,&92%7
W$1=+ %$25&2+)o @,$==D ?1&TB&92 9B215&92O3&9%& ,&$=%o H&C&1$:&% F&24&&9 ,&$=% $93 %./B=3 >/2$59 9B215&92%o IC/53 .5:.O?5F&1 $93 1$4 C&:&2$F=&% $93 B%& -1/OE59&25>%
;&=$+&3 K/B93 M&$=59:o 69>1&$%&3 >$=/15& $93 -1/2&59 592$E&o #/9%B,& ?//3% 452. ]52$,59% ID #D Wo I3&TB$2& ^59> $93 51/9 592$E&
;+%:&B%5$o IC/53 ,&2$= B2&9%5=%D 3159E ?1/, :=$%%o 69>1&$%& %-5>&% $93 ?=$C/1%o 69>/1-/1$2& /2.&1 .5:.O-1/2&59 ?//3% 5? $C&1%5/9 2/ ,&$2%
&A5%2%
Z&1/%2/,5$o Q&3B>& 31+9&%% 452. $125?5>5$= %$=5C$ $93 ,/B2.
,/5%2B15^&1%
o 8%& Y&=%D =/^&9:&%D $93 ,/B2.4$%.&%o @B:$1O?1&& :B, $93 %/B1O?=$C/1&3 .$13 >$93+
W%/-.$:525%o S$+ >$B%& ,B>/%525%D A&1/%2/,5$D $93 /3+9/-.$:5$ %&C&1&
&9/B:. 2/ 2&,-/1$15=+ 35%>/9259B& 1$35$25/9
;&.+31$25/9o 21/=+2& >/11&>25/9o 0&%%$1+ 2/ -1&C&92 4&5:.2 =/%% $93 >/11&>2
&=&>21/=+2& 5,F$=$9>&
6667 NB21525/9 I%%&%%,&92%" ND%26%&0+. +, #*0;$&PQ+7( R+3)+10&0+.S" R%2-62%&* &$* )%&0*.&91 C+7( 3%11 0.7*@ %.7 &$* )*/-*.& 616%2 C+7(
:*0;$&" T+: :+627 &$*0/ 0.&*/)/*&%&0+. 70,,*/4 #$0-$ 01 &$* 3+1&%))/+)/0%&* &+ 61* 0. 7*&*/30.0.; .6&/0&0+.%2 /01F ,+/ &$01 )%&0*.&4
-
8/13/2019 Lymphoma+Case+Study
5/12
`
HS6) "a7[ E:b,GU>B11&92 4&5:.2) "GL -/B93% $93 .&5:.2) `PcdV
e8HK) aG7(eH/3+ S$%% 693&A 5% >$=>B=$2&3 B%59: 2.& -$25&92P% >B11&92 F/3+ 4&5:.2
$93 .&5:.2 2/ $%%&%% 2.& 4&5:.2 >=$%%5?5>$25/97 8%B$= F/3+ 4&5:.2 5%B%&3 2/ >/,-$1& 2.& -$25&92P% >B11&92 F/3+ 4&5:.2 2/ B%B$= F/3+4&5:.2 2/ $%%&%% 2.& 9B21525/9$= 15%E $93 .&$=2. >/,-=5>$25/9%7 8%B$=
F/3+ 4&5:.2 5% 2.&1&?/1& 2.& ,/%2 $--1/-15$2& 2/ B%& 59 3&2&1,5959:
2.& 9B21525/9$= 15%E ?/1 2.& -$25&927
U" #$%& ,%-&+/1 3%( $%D* -+.&/0C6&*7 &+ &$*1* :*0;$& -$%.;*140.& ,$59 >$B%& /? 2.& 4&5:.2 >.$9:&% 5% 3B& 2/ 2.& -$25&92P% 35$:9/%5% /?
>$9>&1D >/9%53&1&3 2/ F& $ -$2./=/:5>$= ?$>2/17 0.& -$25&92 5% &A-&15&9>59:
$ 3&>1&$%&3 $--&252&D ,/%2 =5E&=+ >$B%&3 F+ &$1=+ %$25&2+ $93 ,&2$F/=5>
$=2&1$25/9%7 . ,$+ F& $9 $33525/9$=
>$B%& /? .&1 3&>1&$%& 59 4&5:.27
!V"W10.; &$* 0.,+/3%&0+. ;%&$*/*7 76/0.; (+6/ %11*113*.& +, :*0;$&%.7 C+7( -+3)+10&0+.? 201& )+110C2* .6&/0&0+. )/+C2*31 610.; &$*70%;.+1&0- &*/3"
N6O"7" fM+-&1,&2$F/=5%, U59>1&$%&3 &9&1:+ 9&&3%V N6O"7[ f69$3&TB$2& &9&1:+ 592$E& N6OG7" f69$3&TB$2& /1$= ?//3bF&C&1$:& 592$E& N#O(7G f69C/=B92$1+ 4&5:.2 =/%%
C" R%2-62%&0+. +, X6&/0*.& H*M60/*3*.&1!!"R%2-62%&* &$* )%&0*.&91 )/+&*0. /*M60/*3*.&" N@)2%0. $+: (+6
7*&*/30.*7 &$* %))/+)/0%&* 2*D*2 +, )/+&*0."
7*.&0,( &$*,+/362%P-%2-62%&0+. 3*&$+7 (+6 61*7 %.7 *@)2%0. &$* /%&0+.%2* ,+/610.; 0&" #$%& :*0;$& YWQ# +/ -6//*.& C+7( :*0;$&Z 1$+627 (+6 61*
&+ %--6/%&*2( -%2-62%&* &$* )%&0*.&91 *.*/;( .**714
W9&1:+ 9&&3%) "c(` E>$=O"aLh7` E>$=
0.& 9B215&92 9&&3% /? 2.& >$9>&1 -$25&92 4&1& >$=>B=$2&3 B%59: 2.&
?/1,B=$ ?/1 %=5:.2=+ .+-&1,&2$F/=5> -$25&92% /1 2./%& -$25&92% 4./
9&&3 2/ :$59 4&5:.2D /1 $1& $9$F/=5>D 4.5>. 5% (LO(` E>$=bE:7 0.&
-$25&92 9&&3% $--1/A5,$2&=+ (LO(` E>$=bE: F&>$B%& /? 59C/=B92$1+
4&5:.2 =/%% $93 >B11&92 35%&$%& %2$2&7 K.&9 >$=>B=$259: 2.& &9&1:+
9&&3% 2.& -$25&92P% >B11&92 F/3+ 4&5:.2 4$% B%&37
-
8/13/2019 Lymphoma+Case+Study
6/12
c
>7 692$E& ;/,$59!=B359:
%$=$3D 5>&3 2&$D /1 %E5, ,5=E
@9$>E) -/->/19D />>$%5/9$= -5^^$D %/3$D RB5>&D 5>&3 2&$
-
8/13/2019 Lymphoma+Case+Study
7/12
h
#$1F/.+31$2&) [O`
;$51+) G\1B52) "
1 0&%7*M6%&* &+ 3**& $*/ .**714 N@)2%0."
;5&2$1+ $9$=+%5% %/?24$1& %./B=3 F& B%&3 2/ >$=>B=$2& 2.& -$25&92P%
9B21525/9 592$E& ?1/, G[O./B1 1&>$==7 0.& $,/B92 /? ?//3 >/9%B,&3 59 2.&
-$%2 G[ ./B1% 5% ,B>. F&=/4 2.& 1&>/,,&93$25/9 $93 &9&1:+ 9&&3%7
;&95%& 9&&3% 2/ 59>1&$%& &9&1:+ 592$E& 31$%25>$==+7 15F&3 2/ &92&1$= ?&&3% $2 95:.2 59 /13&1 2/ 59>1&$%& >$=/15> 592$E&7
-
8/13/2019 Lymphoma+Case+Study
8/12
g
!K"#$%& -+33+. 107* *,,*-&1 +, $*/ 022.*11 3%( %,,*-& $*/ 70*&%/(0.&%F* %.7 16C1*M6*.&2( $*/ .6&/0&0+.%2 1&%&6140.& -$25&92 5% :/59: 2/ F&:59 $ >.&,/2.&1$-+ 1&:5,&9 U#MX. 45==
,/%2 =5E&=+ $??&>2 .&1 35&2$1+ 592$E& $93 .&1 .+31$25/9 %2$2B%7 @53& &??&>2%2.$2 $1& $%%/>5$2&3 452. 2.& 21&$2,&92 /? =+,-./,$ $1& 9$B%&$ $93
C/,5259:D 35$11.&$D ,/B2. %/1&%D $93 ?$25:B& ?1/, =/4 1&3 F=//3 >&==>/B92%7 0.&%& %53& &??&>2% 45== 351&>2=+ $??&>2 .&1 9B21525/9$= %2$2B% $93,$E& 52 35??5>B=2 2/ /F2$59 $3&TB$2& &9&1:+D -1/2&59D $93 9B215&92 592$E&
$=/9: 452. .+31$25/97
I,&15>$9 #$9>&1 @/>5&2+
!S"#$%& )$(10-%2 1(3)&+3Y1Z 01 &$01 )%&0*.& *@)*/0*.-0.; &$%& 30;$&%,,*-& $*/ 70*&%/( 0.&%F*4
59: 3&>1&$%&3 $--&252& $93 31+ ,B>/B% ,&,F1$9&%7
0.& -$25&92P% 3&>1&$%&3 $--&252& 5% $ >/,,/9 %53& &??&>2 /? 2.& %2$:& 66
35?B%& =$1:& HO>&== =+,-./,$7 \/12B9$2&=+ 2.& -$25&92 5% 9/2 +&2 $2 $9
&A21&,& 15%E /? ,$=9B21525/9 FB2 .&1 >B11&92 9B21525/9$= %2$2& ,$+ 4/1%&95? $ 35&2 1&:5,&9 5% 9/2 -=$99&37 ;1+ ,B>/B% ,&,F1$9&% 5% >$B%59: $9/9:/59: >/B:. 2.$2 ,$+ $??&>2 2.& 2.1/$2 $93 >/,-=5>$25/9% 452.
%4$==/459:7!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93&37 H&=,/92D #IJ
K$3%4/12. #&9:$:& *&$1959:J GL""7
!U"O/+3 &$* 0.,+/3%&0+. ;%&$*/*7 :0&$0. &$* 0.&%F* 7+3%0.? 201&)+110C2* .6&/0&0+. )/+C2*31 610.; &$* 70%;.+1&0- &*/3"
N6O`7( f69$3&TB$2& -1/2&59O&9&1:+ 592$E& N6O`"7" f69$3&TB$2& ?$2 592$E& N6O`G7" f69$3&TB$2& -1/2&59 592$E& N6O`(7" f69$3&TB$2& >$1F/.+31$2& 592$E&
37 #=595>$= ;/,$595V"#$0-$ 2%C1 -%. C* 61*7 &+ %11*11 )/+&*0. 1&%&614
%" #$0-$ 2%C1 :022 /*,2*-& %-6&* -$%.;*1 0. )/+&*0. 1&%&61 D*/161-$/+.0- -$%.;*14 #$(4
]5%>&1$= -1/2&59 5% $%%&%%&3 F+ %&1B, -1/2&59%D $=FB,59D
21$9%?&1159D -1&$=FB,59D 1&259/= F59359: -1/2&59D $93 ?5F1/9&>2597
I>B2& >.$9:&% 59 -1/2&59 %2$2B% $1& 1&?=&>2&3 F+ -1&$=FB,59D
21$9%?&1159D 1&259/= F59359: -1/2&59D $93 ?5F1/9&>259 =&C&=%7 0.&%&%&1B, -1/2&59% &$>. .$C& $ %./12&1 .$=?O=5?& 2.$9 $=FB,59 $93 $1&
2.&1&?/1& ,/1& %&9%525C& 2/ $>B2& >.$9:&%7 I=FB,59 .$% $ .$=?O=5?&/? "hOG" 3$+% $93 5% /?2&9 $ ://3 5935>$2/1 /? >.1/95> >.$9:&%7
!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93&37 H&=,/92D #IJ
K$3%4/12. #&9:$:& *&$1959:J GL""7
-
8/13/2019 Lymphoma+Case+Study
9/12
a
C" #$0-$ %/* %D%02%C2* ,+/ &$01 )%&0*.&4 R+.107*/0.; $*/70%;.+101? :$0-$ 2%C1 :+627 .+& C* %))/+)/0%&* &+ 61* &+*D%26%&* )/+&*0. 1&%&614
0/2$= -1/2&59 $93 I=FB,59 =&C&=% $1& $C$5=$F=&D 5935>$259: =/4-1/2&59 =&C&=%7 H&>$B%& /? -$25&92P% >/93525/9D \5F1/9&>259 =&C&=%
4/B=3 9/2 F& $--1/-15$2&7
-" E*&*/30.* &$* .6&/0&0+.%2 /01F %11+-0%&*7 :0&$ &$01 )%&0*.&912%C+/%&+/( D%26*" #+627 (+6 /*M6*1& %770&0+. .6&/0&0+. 2%C14
I3
&
T
B
$2
&
5
,,
B
9
&
I33525/9$= =$F C$=B&% 2/ F& /13&1&3 %./B=3 F& -1&$=FB,59 $93
21$9%?&1159 =&C&=% 2/ &C$=B$2& %./12O2&1, -1/2&59 %2$2B%7 #OQ&$>25C&
$2& =&C&= /? 59?=$,,$25/97
5!">7*.&0,( *%-$ +, &$* 7/6;1 &$%& &$* )%&0*.& 01 )/*1-/0C*7? %.7 .+&* &$*)+110C2* .6&/0&0+.%2 107* *,,*-&1 +, *%-$" >. ;*.*/%2? :$%& 30;$& (+6
&*22 &$01 )%&0*.& &+ *@)*-& ,/+3 /*-*0D0.; $*/ -$*3+&$*/%)(4
;1B:% 2U%V
#+>=/-./%-.$,53& N$B%&$ $93 C/,5259:D =/%% /? $--&252&D %/1&% 59 ,/B2.D35$11.&$
;/A/1BF5>59 N$B%&$ $93 C/,5259:D %/1&% 59 2.& ,/B2.D $93 -/%%5F=&
$==&1:5> 1&$>25/9%
]59>15%259& N$B%&$ $93 C/,5259:D %/1&% 59 2.& ,/B2.D >/9%25-$25/9D =/%%
/? $--&252&
$=>5B, ?1/, F/9&%D 31+ ,/B2. $93 %/1& 2.1/$2D
4&5:.2 :$59D
QW06# H/9& S$11/4 I>25C52+
M5:. F&>$B%& /? >.1/95>
35%&$%&
S#]
US&$9 >/1-B%>B=$1 C/=B,&V
@5^& /? QH#
*/4) S$+ 5935>$2& 51/9
3&?5>5&9>+
MYH UM&,/:=/F59V */4) #.1/95> 35%&$%& %2$2&M#0 UM&,$2/>152V */4) B=$1
M&,/:=/F59 #/9>&921$25/9V
*/4) 5&9>+ /1F&>$B%& /? 35%&$%&
-
8/13/2019 Lymphoma+Case+Study
10/12
"L
I,&15>$9 #$9>&1 @/>5&2+
GG7\1/, 2.5% 59?/1,$25/9 :$2.&1&3 452.59 2.& >=595>$= 3/,$59D =5%2 -/%%5F=&9B21525/9 -1/F=&,% B%59: 2.& 35$:9/%25> 2&1,7
69C/=B92$1+ 4&5:.2 =/%% N#O(7G*" Q*$%D0+/%2[N.D0/+.3*.&%2 E+3%0.51&$%&3 $--&252& $93 ?$25:B&$% &C53&9>& F+ G[O./B1 1&>$==D 1&>&92 4&5:.2 =/%% /? "L -/B93%D $93
:&9&1$= $--&$1$9>&7G7 69C/=B92$1+ 4&5:.2 =/%% 1&=$2&3 2/ 59$3&TB$2& &9&1:+ 592$E& $%
&C53&9>& F+ 1&>&92 4&5:.2 =/%% /? "L -/B93%D $93 G[O./B1 1&>$==7
]7 NB21525/9 692&1C&925/95G"O+/ *%-$ +, &$* _N= 1&%&*3*.&1 &$%& (+6 $%D* :/0&&*.? *1&%C201$ %.
07*%2 ;+%2 YC%1*7 +. &$* 10;.1 %.7 1(3)&+31Z %.7 %. %))/+)/0%&*
0.&*/D*.&0+. YC%1*7 +. *&0+2+;(Z"
-
8/13/2019 Lymphoma+Case+Study
11/12
""
"7 Y/$=) 69>1&$%& ?//3 592$E& 2.1/B:. 9B21525/9 2.&1$-+ 2/ 5,-1/C&9B21525/9$= %2$2B%7692&1C&925/9) S/35?+ ?//3 592$E& 2/ [ %,$== ?&&359:% /? (LL >$=/15&%J
59>1&$%& 9B215&92 3&9%52+J -1/C53& &C53&9>&OF$%&3 59?/1,$25/91&:$1359: 9B21525/9$= 9&&3% 3B159: 21&$2,&92 ?/1 =+,-./,$ $93
-1/-&1 ?//3 >./5>&%7G7 Y/$=) /9%53&1 ?/==/459: $ =/4O,5>1/F5$= 35&2 3B159: 2.& 59525$=
24/ ,/92.% /? >.&,/2.&1$-+ 2/ 1&3B>& 2.& 15%E /? 3&C&=/-59: $ ?//3O
1&=$2&3 59?&>25/97 6,,B9/%B--1&%%5/9 3B159: >.&,/2.&1$-+ >$B%&% $4&$E&9&3 5,,B9& %+%2&, 2.$2 59>1&$%&% -/2&925$= 59?&>25/9% -/2&925$=
-
8/13/2019 Lymphoma+Case+Study
12/12
"G
%/B1>&% /? /1:$95%,% E9/49 2/ >$B%& 59?&>25/97 I =/4O,5>1/F5$= 35&2
,&&2 2.& Q&>/,,&93&3 ;5&2$1+ 692$E&% /? 2.& N$25/9$= Q&%&$1>. #/B9>5=?/1 $== 9B215&92% 4.&9 ?/==/459: $ 4&==OF$=$9>&3 35&27 Y&9&1$=
>/9%53&1$25/9% 59>=B3&)
;5%>$13 $9+ ?//3 452. ,/=3 ;/ 9/2 -B1>.$%& $ -1/3B>2 $?2&1 2.& &A-51$25/9 3$2& I== ?//3% ,B%2 F& %2/1&3 $93 .$93=&3 -1/-&1=+8# ;$C5% #$9>&1 #&92&1
5U"H*-*.&2( ;26&%30.* $%1 C**. % -+3)+.*.& +, 1*D*/%2 -20.0-%2 &/0%21 &+/*76-* ;%1&/+0.&*1&0.%2 -+3)20-%&0+.1 +, C+&$ -$*3+ %.7 /%70%&0+.
&$*/%)(" #$%& 01 ;26&%30.*4 #$%& 01 &$* /%&0+.%2 ,+/ 0&1 61*4
Y=B2$,59& 5% $9 $,59/ $>53 2.$2 .$% F&&9 %2B35&3 2/ 3&2&1,59& 5? 52 >$9&??&>25C&=+ 1&3B>& >$9>&1 21&$2,&92 %53& &??&>2% %B>. $% ,B>/%525%D
9&B1/-$2.+D $12.1$=:5$D ,+$=:5$D $93 35$11.&$7 0.& %2B35&% >/93B>2&3
.$C& 9/2 ?/B93 %21/9: &9/B:. &C53&9>& 2/ >/9>=B3& 2.$2 $9 $%%/>5$25/9
3/&% &A5%27 0.& >=/%&%2 $%%/>5$25/9 2.$2 .$% F&&9 ?/B93 5% F&24&&9 2.&/>>B11&9>& /? ,B>/%525% $93 B%& /? :=B2$,59&7 \B12.&1 1&%&$1>. 9&&3% 2/F& >/,-=&2&3 2/ $>>B1$2&=+ $%%&%% 2.& >/11&=$25/97
#$159:[#$9>&1
Q&?&1&9>&%)
I;I WC53&9>& *5F1$1+ UGLLcV7 NB21525/9 ;5$:9/%5%7
#$9>&1 01&$2,&92 #&92&1% ?/1 I,&15>$7 HO#&== *+,-./,$7
692&19$25/9$= ;5&2&25>% $93 NB21525/9 0&1,59/=/:+ U6;N0V Q&?&1&9>& S$9B$=)
@2$93$135^&3 *$9:B$:& ?/1 2.& NB21525/9 #$1& &%%7 (13W37 #.5>$:/D 6*)
I,&15>$9 ;5&2&25>% I%%/>5$25/9J GL""7
S$>,5==$9 #$9>&1 @B--/12 UGL"LV7 S&35$%259$= =$1:& HO>&== =+,-./,$7
N$25/9$= #$9>&1 69%252B2& UGLLaV7 W$259: M592%7
N$25/9$= #$9>&1 69%252B2& UGL""V7 NB21525/9 59 #$9>&1 #$1&7
!"#$%#%&' )*+$,-. ,'/ 0,#*&-*.1%&2&3.7 G93&37 H&=,/92D #IJ K$3%4/12. #&9:$:&
*&$1959:J GL""7
0.& #=&C&=$93 #=595>7 I3B=2 N/9OM/3:E59% *+,-./,$7
top related